Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LC28-0126 in STEMI patients undergoing PCI
NCT02070471Phase 2Completed
- Sponsor
- LG Chem
- Start
- Jan 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LC28-0126 in ST-segment elevation myocardial infarction (STEMI), sponsored by LG Chem. Started Jan 2014; status: completed.
02
Drugs
LC28-0126
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT02070471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02070471.